Cargando…

Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial

INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiun-Ruey, Wu, Yingfei, Sacks, Frank M, Appel, Lawrence J, Miller III, Edgar R, Young, J Hunter, Juraschek, Stephen P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462151/
https://www.ncbi.nlm.nih.gov/pubmed/32868311
http://dx.doi.org/10.1136/bmjdrc-2020-001457
_version_ 1783576861359472640
author Hu, Jiun-Ruey
Wu, Yingfei
Sacks, Frank M
Appel, Lawrence J
Miller III, Edgar R
Young, J Hunter
Juraschek, Stephen P
author_facet Hu, Jiun-Ruey
Wu, Yingfei
Sacks, Frank M
Appel, Lawrence J
Miller III, Edgar R
Young, J Hunter
Juraschek, Stephen P
author_sort Hu, Jiun-Ruey
collection PubMed
description INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal from carbohydrate (40% kcal (c)) versus high (58% kcal (C)) each would reduce lactate levels. RESEARCH DESIGN AND METHODS: We measured lactate in OmniCarb, a randomized, cross-over trial of four diets in overweight/obese adults without diabetes or cardiovascular disease (N=163). The four diets were high carbohydrate+high GI (CG, reference), high carbohydrate+low GI (Cg), low carbohydrate+high GI (cG), and low carbohydrate+low GI (cg). Participants (N=163) consumed each of the four diets over a 5-week period, separated by 2-week washout periods. Plasma lactate levels were measured at baseline, during which the participants consumed their own diets, and after each 5-week period. RESULTS: Baseline plasma lactate was 1.2 mmol/L. In the setting of high carbohydrate amount, reducing GI lowered plasma lactate non-significantly by 0.08 mmol/L (Cg vs CG: 95% CI −0.16 to 0.00; p=0.06). In the setting of high GI, reducing carbohydrate amount lowered plasma lactate by 0.10 mmol/L (cG vs CG: 95% CI −0.19 to −0.02; p=0.02). The combined effect of reducing GI and carbohydrate proportion in the diet (cg vs CG) was similar (cg vs CG: −0.08; 95% CI −0.16 to 0.00; p=0.04). All four diets reduced plasma lactate compared with baseline. CONCLUSIONS: Compared with a diet with high GI and high carbohydrate amount, diets with low GI and/or low carbohydrate amount reduced plasma lactate. Whether this change in lactate leads to long-term change in glucose metabolism needs to be examined. TRIAL REGISTRATION NUMBER: NCT00608049.
format Online
Article
Text
id pubmed-7462151
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-74621512020-09-11 Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial Hu, Jiun-Ruey Wu, Yingfei Sacks, Frank M Appel, Lawrence J Miller III, Edgar R Young, J Hunter Juraschek, Stephen P BMJ Open Diabetes Res Care Clinical care/Education/Nutrition INTRODUCTION: Plasma lactate is a marker of non-oxidative glucose metabolism associated with progression to diabetes. We examined the effect of carbohydrate quality (glycemic index (GI)) and amount (%kcal) on plasma lactate. We hypothesized that low GI (≤45 (g)) versus high (≥65 (G)) and low %kcal from carbohydrate (40% kcal (c)) versus high (58% kcal (C)) each would reduce lactate levels. RESEARCH DESIGN AND METHODS: We measured lactate in OmniCarb, a randomized, cross-over trial of four diets in overweight/obese adults without diabetes or cardiovascular disease (N=163). The four diets were high carbohydrate+high GI (CG, reference), high carbohydrate+low GI (Cg), low carbohydrate+high GI (cG), and low carbohydrate+low GI (cg). Participants (N=163) consumed each of the four diets over a 5-week period, separated by 2-week washout periods. Plasma lactate levels were measured at baseline, during which the participants consumed their own diets, and after each 5-week period. RESULTS: Baseline plasma lactate was 1.2 mmol/L. In the setting of high carbohydrate amount, reducing GI lowered plasma lactate non-significantly by 0.08 mmol/L (Cg vs CG: 95% CI −0.16 to 0.00; p=0.06). In the setting of high GI, reducing carbohydrate amount lowered plasma lactate by 0.10 mmol/L (cG vs CG: 95% CI −0.19 to −0.02; p=0.02). The combined effect of reducing GI and carbohydrate proportion in the diet (cg vs CG) was similar (cg vs CG: −0.08; 95% CI −0.16 to 0.00; p=0.04). All four diets reduced plasma lactate compared with baseline. CONCLUSIONS: Compared with a diet with high GI and high carbohydrate amount, diets with low GI and/or low carbohydrate amount reduced plasma lactate. Whether this change in lactate leads to long-term change in glucose metabolism needs to be examined. TRIAL REGISTRATION NUMBER: NCT00608049. BMJ Publishing Group 2020-08-31 /pmc/articles/PMC7462151/ /pubmed/32868311 http://dx.doi.org/10.1136/bmjdrc-2020-001457 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Clinical care/Education/Nutrition
Hu, Jiun-Ruey
Wu, Yingfei
Sacks, Frank M
Appel, Lawrence J
Miller III, Edgar R
Young, J Hunter
Juraschek, Stephen P
Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title_full Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title_fullStr Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title_full_unstemmed Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title_short Effects of carbohydrate quality and amount on plasma lactate: results from the OmniCarb trial
title_sort effects of carbohydrate quality and amount on plasma lactate: results from the omnicarb trial
topic Clinical care/Education/Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462151/
https://www.ncbi.nlm.nih.gov/pubmed/32868311
http://dx.doi.org/10.1136/bmjdrc-2020-001457
work_keys_str_mv AT hujiunruey effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT wuyingfei effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT sacksfrankm effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT appellawrencej effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT milleriiiedgarr effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT youngjhunter effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial
AT juraschekstephenp effectsofcarbohydratequalityandamountonplasmalactateresultsfromtheomnicarbtrial